In This Section

Postdoctoral Opportunities at Fels Institute for Cancer Research

Fels Institute (Temple University, Philadelphia, PA) has several openings for a postdoctoral position in Cancer related fields. PIs with openings include:

  • Dr. Raza Zaidi (mechanism of UV induced malignancies)
  • Dr. Italo Tempera (Epigenetics and EBV control)

Dr. Raza Zaidi

A postdoctoral position is available to investigate the role of Interferon-gamma in ultraviolet radiation-induced melanoma genesis (see Nature 469:548). Applicants should have a PhD, a background in mouse models of cancer, and proficiency in a range of molecular/cell biology, immunological and genomic techniques, including tissue culture, flow cytometry, microarrays, and immunocytochemistry. Experience with mice is a requirement. Experience with tumor immunology will be highly desirable. Candidate should be highly motivated, creative, with strong work ethic and ability to work independently as well as in collaborative research efforts. The position will be filled for one year with possible extension, and salary will be commensurate with experience. Please submit application electronically with curriculum vitae, statement of research interests, and the names/phone numbers/emails of three people who can provide letters of reference to: Dr. Raza Zaidi, Fels Institute of Cancer Research and Molecular Biology, Temple School of Medicine, Philadelphia, PA. Email: zaidi@temple.edu.
 
Dr. Italo Tempera

To study the role of chromatin organization in the regulation of gene expression in the context of Epstein-Barr virus infection and its impact on viral etiology of cancer. The goal of this project is to understand how EBV interferes with the mechanisms that regulate chromatin architecture and exploit them to promote and support viral infection. Two related projects are available. The first is a genome-wide investigation of the role of host chromatin remodeling factors on the chromatin organization of EBV genome and their impact on the carcinogenic risk of EBV infection. The second is a molecular and biochemical study of how EBV gene expression is rapidly reprogrammed in response to external stimuli by changes in the viral chromosome architecture. The knowledge gained by the EBV study will be translated to explore the role of chromatin architecture in the human genome. The successful candidate will be highly motivated and collaborative. He or she is expected to actively contribute to the research plan and significantly contribute in the preparation of publications and grants. The successful candidate will work in the very stimulating and collaborative environment of the Fels Institute. Requirements include a PhD in Virology, Biochemistry, Molecular or Cell Biology, or comparably related fields. Candidates with the experience in EBV or other cancer-associated viruses, chromatin and epigenetics, molecular techniques including ChIp and 3C are encouraged to apply. Additional preference will be given to applicants with good communication skills. Salary follows NIH guidelines. Please submit application electronically with curriculum vitae, statement of research interests, and the names/phone numbers/emails of three people who can provide letters of reference to: Dr. Italo Tempera, Fels Institute of Cancer Research and Molecular Biology, Temple School of Medicine, Philadelphia, PA. Email: tempera@temple.edu.